PER 1.23% 8.2¢ percheron therapeutics limited

Ionis drug approval

  1. 300 Posts.
    lightbulb Created with Sketch. 833
    Ionis gains approval on Tofersen in Europe overnight. Very good news as this is also a second-generation antisense oligonucleotide (as ATL1102). This one is also for a rare disease ALS

    Tofersen is all about mediating mRNA degradation to prevent SOD1 protein synthesis and reduce levels of SOD1 protein.

    A nice precedent for ATL1102.


    https://www.prnewswire.com/news-releases/ionis-announces-european-medicines-agency-accepts-marketing-authorization-application-of-tofersen-to-treat-rare-genetic-form-of-als-301694129.html
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.001(1.23%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.2¢ $37.86K 461.7K

Buyers (Bids)

No. Vol. Price($)
3 142709 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 114750 3
View Market Depth
Last trade - 12.44pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.